ARCHIVES

In Brief: Pittsburgh Joins List Of Comprehensive Center Prospect; FDA Schedules Meeting On Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 01 No. 28 | July 11, 1975

Download PDF Visit The Full Archive

Related Articles

FY 2000 Budget: Success Rate Drops Projected, Would Take Years to Catch Up

February 19, 1999

Reports Propose Stricter Rules To Protect Research Participants

October 11, 2002

ICCCR Issues RFP For Cancer Risk Scale

March 6, 1992

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

October 31, 2014

National Cancer Institute Lists Approved Clinical Trials

January 31, 2003

Regions Outlined In CIS Proposal

May 31, 1991